Ardelyx (ARDX) Non-Current Deffered Revenue (2013 - 2026)

Ardelyx (ARDX) reported Non-Current Deffered Revenue of $13.7 million for Q1 2026, up 64.06% on a YoY basis from $8.4 million in Q1 2025, and little changed quarter-over-quarter from $13.7 million in Q4 2025.

Ardelyx (ARDX) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

Ardelyx has reported Non-Current Deffered Revenue for 9 years, with the latest figure at $13.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deffered Revenue rose 64.06% year-over-year to $13.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.7 million (up 64.06% YoY), and the FY2025 full-year result was $13.7 million, up 89.42% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $13.7 million, roughly flat from $13.7 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $13.7 million in Q3 2025, with the low at $7.2 million in Q4 2024.
  • Historically, Non-Current Deffered Revenue has averaged $10.7 million across 5 years, with a median of $10.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue soared 321.48% — and 2025, when it sank 31.01%.
  • Ardelyx's Non-Current Deffered Revenue stood at $9.0 million in 2022, then declined by 4.22% to $8.6 million in 2023, then dropped by 16.34% to $7.2 million in 2024, then soared by 89.42% to $13.7 million in 2025, then changed by 0.0% to $13.7 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $13.7 million (Q1 2026), $13.7 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 13.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.70 Mn
Dec 31, 2025 13.70 Mn
Sep 30, 2025 13.70 Mn
Jun 30, 2025 12.30 Mn
Mar 31, 2025 8.35 Mn
Dec 31, 2024 7.23 Mn
Sep 30, 2024 12.77 Mn
Jun 30, 2024 9.61 Mn
Mar 31, 2024 12.10 Mn
Dec 31, 2023 8.64 Mn
Sep 30, 2023 10.29 Mn
Jun 30, 2023 9.24 Mn
Mar 31, 2023 11.50 Mn
Dec 31, 2022 9.03 Mn
Sep 30, 2022 8.56 Mn
Jun 30, 2022 12.42 Mn
Mar 31, 2022 8.56 Mn
Dec 31, 2021 4.73 Mn
Sep 30, 2021 2.95 Mn
Jun 30, 2021 2.95 Mn